Shopping Cart 0
Cart Subtotal
USD 0

Germany Needle Free Injections Market Outlook to 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4995

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 9990

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 14985
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Germany Needle Free Injections Market Outlook to 2023

Summary

GlobalData's new report, "Germany Needle Free Injections Market Outlook to 2023", provides key market data on the Germany Needle Free Injections market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) for Needle Free Injections.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Needle Free Injections.

Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.

2016 company shares and distribution shares data for each of the market segments.

Global corporate-level profiles of key companies operating within the Germany Needle Free Injections market.

Key players covered include INJEX-Equidyne Systems, Bioject Medical Technologies Inc and Antares Pharma Inc.

Reasons to buy

Develop business strategies by identifying the key market segments poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 3

1.2 List of Figures 3

2 Introduction 4

2.1 What Is This Report About? 4

2.2 Needle Free Injections Market Segmentation 4

2.3 Definitions of Markets Covered in the Report 5

3 Needle Free Injections Market, Germany 6

3.1 Needle Free Injections Market, Germany, Revenue ($m), 2009-2016 6

3.2 Needle Free Injections Market, Germany, Revenue ($m), 2016-2023 7

3.3 Needle Free Injections Market, Germany, Volume (Units), 2009-2016 8

3.4 Needle Free Injections Market, Germany, Volume (Units), 2016-2023 9

3.5 Needle Free Injections Market, Germany, Average Price ($), 2009-2023 10

3.6 Needle Free Injections Market, Germany, Distribution Share by Revenue ($m), 2015-2016 11

3.7 Needle Free Injections Market, Germany, Company Share by Revenue ($m), 2016 12

4 Overview of Key Companies in Germany, Needle Free Injections Market 14

4.1 INJEX-Equidyne Systems 14

4.1.1 Company Overview 14

4.2 Bioject Medical Technologies Inc 14

4.2.1 Company Overview 14

4.3 Antares Pharma Inc 14

4.3.1 Company Overview 14

4.4 PharmaJet Inc 14

4.4.1 Company Overview 14

5 Needle Free Injections Market Pipeline Products 15

6 Recent Developments 16

6.1 Corporate Communications 16

6.1.1 Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 16

6.1.2 Feb 22, 2017: Change in the B. Braun Management Board 16

6.2 Financial Announcements 16

6.2.1 Mar 31, 2017: B. Braun continues its sales and earnings growth 16

6.3 Other Significant Developments 18

6.3.1 Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund 18

7 Appendix 19

7.1 Research Methodology 20

7.1.1 Coverage 20

7.1.2 Secondary Research 20

7.1.3 Primary Research 21

7.1.4 Company Share Analysis 21

7.1.5 Distribution Share Analysis 21

7.1.6 Benchmarking 22

7.2 GlobalData Consulting 22

7.3 Contact Us 23

7.4 Disclaimer 23


List Of Figure

1.2 List of Figures

Figure 1: Needle Free Injections Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016 6

Figure 2: Needle Free Injections Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023 7

Figure 3: Needle Free Injections Market, Germany, Volume (Units), Historic, 2009-2016 8

Figure 4: Needle Free Injections Market, Germany, Volume (Units), Forecast, 2016-2023 9

Figure 5: Needle Free Injections Market, Germany, Company Share (%) 2016 12


List Of Table

1.1 List of Tables

Table 1: Needle Free Injections Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016 6

Table 2: Needle Free Injections Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023 7

Table 3: Needle Free Injections Market, Germany, Volume (Units), Historic, 2009-2016 8

Table 4: Needle Free Injections Market, Germany, Volume (Units), Forecast, 2016-2023 9

Table 5: Needle Free Injections Market, Germany, Average Price ($), Historic, 2009-2016 10

Table 6: Needle Free Injections Market, Germany, Average Price ($), Forecast, 2016-2023 10

Table 7: Needle Free Injections Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2015-2016 11

Table 8: Needle Free Injections Market, Germany, Company Share by Revenue ($m), USD Constant, 2016 13

Table 9: Needle Free Injections Market Pipeline Products 15

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Drug Delivery Devices, Central Venous Catheters, Needle Free Injections, Infusion Systems, Metered Dose Inhaler Devices, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, GlaxoSmithKline Plc, AstraZeneca Plc, Boehringer Ingelheim GmbH, Pfizer Inc, Merck & Co Inc, Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, INJEX-Equidyne Systems, Bioject Medical Technologies Inc , Antares Pharma Inc, PharmaJet Inc, MK Global Co., The European Pharma Group, Hospira Inc, Becton Dickinson and Co, Baxter International Inc, Fresenius Kabi AG, Medtronic plc, B. Braun Melsungen AG, Terumo Corp, Smiths Medical, Nipro Corp, JMS Co Ltd


Companies

INJEX-Equidyne Systems

Bioject Medical Technologies Inc

Antares Pharma Inc

PharmaJet Inc

Germany Needle Free Injections Market Outlook to 2023

Summary

GlobalData's new report, "Germany Needle Free Injections Market Outlook to 2023", provides key market data on the Germany Needle Free Injections market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) for Needle Free Injections.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Needle Free Injections.

Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.

2016 company shares and distribution shares data for each of the market segments.

Global corporate-level profiles of key companies operating within the Germany Needle Free Injections market.

Key players covered include INJEX-Equidyne Systems, Bioject Medical Technologies Inc and Antares Pharma Inc.

Reasons to buy

Develop business strategies by identifying the key market segments poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

READ MORE

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 3

1.2 List of Figures 3

2 Introduction 4

2.1 What Is This Report About? 4

2.2 Needle Free Injections Market Segmentation 4

2.3 Definitions of Markets Covered in the Report 5

3 Needle Free Injections Market, Germany 6

3.1 Needle Free Injections Market, Germany, Revenue ($m), 2009-2016 6

3.2 Needle Free Injections Market, Germany, Revenue ($m), 2016-2023 7

3.3 Needle Free Injections Market, Germany, Volume (Units), 2009-2016 8

3.4 Needle Free Injections Market, Germany, Volume (Units), 2016-2023 9

3.5 Needle Free Injections Market, Germany, Average Price ($), 2009-2023 10

3.6 Needle Free Injections Market, Germany, Distribution Share by Revenue ($m), 2015-2016 11

3.7 Needle Free Injections Market, Germany, Company Share by Revenue ($m), 2016 12

4 Overview of Key Companies in Germany, Needle Free Injections Market 14

4.1 INJEX-Equidyne Systems 14

4.1.1 Company Overview 14

4.2 Bioject Medical Technologies Inc 14

4.2.1 Company Overview 14

4.3 Antares Pharma Inc 14

4.3.1 Company Overview 14

4.4 PharmaJet Inc 14

4.4.1 Company Overview 14

5 Needle Free Injections Market Pipeline Products 15

6 Recent Developments 16

6.1 Corporate Communications 16

6.1.1 Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 16

6.1.2 Feb 22, 2017: Change in the B. Braun Management Board 16

6.2 Financial Announcements 16

6.2.1 Mar 31, 2017: B. Braun continues its sales and earnings growth 16

6.3 Other Significant Developments 18

6.3.1 Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund 18

7 Appendix 19

7.1 Research Methodology 20

7.1.1 Coverage 20

7.1.2 Secondary Research 20

7.1.3 Primary Research 21

7.1.4 Company Share Analysis 21

7.1.5 Distribution Share Analysis 21

7.1.6 Benchmarking 22

7.2 GlobalData Consulting 22

7.3 Contact Us 23

7.4 Disclaimer 23


List Of Figure

1.2 List of Figures

Figure 1: Needle Free Injections Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016 6

Figure 2: Needle Free Injections Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023 7

Figure 3: Needle Free Injections Market, Germany, Volume (Units), Historic, 2009-2016 8

Figure 4: Needle Free Injections Market, Germany, Volume (Units), Forecast, 2016-2023 9

Figure 5: Needle Free Injections Market, Germany, Company Share (%) 2016 12


List Of Table

1.1 List of Tables

Table 1: Needle Free Injections Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016 6

Table 2: Needle Free Injections Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023 7

Table 3: Needle Free Injections Market, Germany, Volume (Units), Historic, 2009-2016 8

Table 4: Needle Free Injections Market, Germany, Volume (Units), Forecast, 2016-2023 9

Table 5: Needle Free Injections Market, Germany, Average Price ($), Historic, 2009-2016 10

Table 6: Needle Free Injections Market, Germany, Average Price ($), Forecast, 2016-2023 10

Table 7: Needle Free Injections Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2015-2016 11

Table 8: Needle Free Injections Market, Germany, Company Share by Revenue ($m), USD Constant, 2016 13

Table 9: Needle Free Injections Market Pipeline Products 15

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Drug Delivery Devices, Central Venous Catheters, Needle Free Injections, Infusion Systems, Metered Dose Inhaler Devices, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, GlaxoSmithKline Plc, AstraZeneca Plc, Boehringer Ingelheim GmbH, Pfizer Inc, Merck & Co Inc, Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, INJEX-Equidyne Systems, Bioject Medical Technologies Inc , Antares Pharma Inc, PharmaJet Inc, MK Global Co., The European Pharma Group, Hospira Inc, Becton Dickinson and Co, Baxter International Inc, Fresenius Kabi AG, Medtronic plc, B. Braun Melsungen AG, Terumo Corp, Smiths Medical, Nipro Corp, JMS Co Ltd


Companies

INJEX-Equidyne Systems

Bioject Medical Technologies Inc

Antares Pharma Inc

PharmaJet Inc

chat_bubbleLet's Chat